HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights

Barbara Shacklett, Cynthia A. Derdeyn, Morenike Oluwatoyin Folayan, Raphael J. Landovitz, Colin Anthony, Anna Janina Behrens, Thomas J. Hope, Elise Landais, Lorna Leal, Jeanne M. Marrazzo, Lynn Morris, Nelly Mugo, Kenneth Ngure, Veronica Noseda, Srinika Ranasinghe, Damien C. Tully, Yegor Voronin, Mitchell Warren, Constantinos Kurt Wibmer, Irene Y. XieGabriella Scarlatti, Bargavi Thyagarajan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.

Original languageEnglish (US)
Pages (from-to)749-759
Number of pages11
JournalAIDS Research and Human Retroviruses
Volume33
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

HIV
AIDS Vaccines
Research
Research Personnel
Anti-Infective Agents
Webcasts
Acquired Immunodeficiency Syndrome

Keywords

  • antibody
  • HIV prevention
  • microbicide
  • PrEP
  • R4P
  • vaccine

ASJC Scopus subject areas

  • Immunology
  • Infectious Diseases
  • Virology

Cite this

Shacklett, B., Derdeyn, C. A., Folayan, M. O., Landovitz, R. J., Anthony, C., Behrens, A. J., ... Thyagarajan, B. (2017). HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights. AIDS Research and Human Retroviruses, 33(8), 749-759. https://doi.org/10.1089/aid.2017.0125

HIVR4P 2016, Partnering for Prevention : Conference Summary and Highlights. / Shacklett, Barbara; Derdeyn, Cynthia A.; Folayan, Morenike Oluwatoyin; Landovitz, Raphael J.; Anthony, Colin; Behrens, Anna Janina; Hope, Thomas J.; Landais, Elise; Leal, Lorna; Marrazzo, Jeanne M.; Morris, Lynn; Mugo, Nelly; Ngure, Kenneth; Noseda, Veronica; Ranasinghe, Srinika; Tully, Damien C.; Voronin, Yegor; Warren, Mitchell; Wibmer, Constantinos Kurt; Xie, Irene Y.; Scarlatti, Gabriella; Thyagarajan, Bargavi.

In: AIDS Research and Human Retroviruses, Vol. 33, No. 8, 01.08.2017, p. 749-759.

Research output: Contribution to journalArticle

Shacklett, B, Derdeyn, CA, Folayan, MO, Landovitz, RJ, Anthony, C, Behrens, AJ, Hope, TJ, Landais, E, Leal, L, Marrazzo, JM, Morris, L, Mugo, N, Ngure, K, Noseda, V, Ranasinghe, S, Tully, DC, Voronin, Y, Warren, M, Wibmer, CK, Xie, IY, Scarlatti, G & Thyagarajan, B 2017, 'HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights', AIDS Research and Human Retroviruses, vol. 33, no. 8, pp. 749-759. https://doi.org/10.1089/aid.2017.0125
Shacklett, Barbara ; Derdeyn, Cynthia A. ; Folayan, Morenike Oluwatoyin ; Landovitz, Raphael J. ; Anthony, Colin ; Behrens, Anna Janina ; Hope, Thomas J. ; Landais, Elise ; Leal, Lorna ; Marrazzo, Jeanne M. ; Morris, Lynn ; Mugo, Nelly ; Ngure, Kenneth ; Noseda, Veronica ; Ranasinghe, Srinika ; Tully, Damien C. ; Voronin, Yegor ; Warren, Mitchell ; Wibmer, Constantinos Kurt ; Xie, Irene Y. ; Scarlatti, Gabriella ; Thyagarajan, Bargavi. / HIVR4P 2016, Partnering for Prevention : Conference Summary and Highlights. In: AIDS Research and Human Retroviruses. 2017 ; Vol. 33, No. 8. pp. 749-759.
@article{d3b08ad9b0d7409f8252c01c2ade49e3,
title = "HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights",
abstract = "HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme {"}Partnering for Prevention{"} represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.",
keywords = "antibody, HIV prevention, microbicide, PrEP, R4P, vaccine",
author = "Barbara Shacklett and Derdeyn, {Cynthia A.} and Folayan, {Morenike Oluwatoyin} and Landovitz, {Raphael J.} and Colin Anthony and Behrens, {Anna Janina} and Hope, {Thomas J.} and Elise Landais and Lorna Leal and Marrazzo, {Jeanne M.} and Lynn Morris and Nelly Mugo and Kenneth Ngure and Veronica Noseda and Srinika Ranasinghe and Tully, {Damien C.} and Yegor Voronin and Mitchell Warren and Wibmer, {Constantinos Kurt} and Xie, {Irene Y.} and Gabriella Scarlatti and Bargavi Thyagarajan",
year = "2017",
month = "8",
day = "1",
doi = "10.1089/aid.2017.0125",
language = "English (US)",
volume = "33",
pages = "749--759",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - HIVR4P 2016, Partnering for Prevention

T2 - Conference Summary and Highlights

AU - Shacklett, Barbara

AU - Derdeyn, Cynthia A.

AU - Folayan, Morenike Oluwatoyin

AU - Landovitz, Raphael J.

AU - Anthony, Colin

AU - Behrens, Anna Janina

AU - Hope, Thomas J.

AU - Landais, Elise

AU - Leal, Lorna

AU - Marrazzo, Jeanne M.

AU - Morris, Lynn

AU - Mugo, Nelly

AU - Ngure, Kenneth

AU - Noseda, Veronica

AU - Ranasinghe, Srinika

AU - Tully, Damien C.

AU - Voronin, Yegor

AU - Warren, Mitchell

AU - Wibmer, Constantinos Kurt

AU - Xie, Irene Y.

AU - Scarlatti, Gabriella

AU - Thyagarajan, Bargavi

PY - 2017/8/1

Y1 - 2017/8/1

N2 - HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.

AB - HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.

KW - antibody

KW - HIV prevention

KW - microbicide

KW - PrEP

KW - R4P

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85027027920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027027920&partnerID=8YFLogxK

U2 - 10.1089/aid.2017.0125

DO - 10.1089/aid.2017.0125

M3 - Article

C2 - 28649869

AN - SCOPUS:85027027920

VL - 33

SP - 749

EP - 759

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 8

ER -